Table 5 Multivariable relative risks for subsequent primary meningiomas for survivors of CNS tumours and leukaemia.

From: Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study

Factor

Exposure

CNS tumour

Leukaemia

  

RR (95% CI)a

RR (95% CI)a

Cranial radiotherapyb

No

1.0 (ref.)

1.0 (ref.)

 

Yes

13.0 (6.7–25.4)

5.4 (2.9–9.9)

 

Unknown

6.7 (3.2–14.2)

3.0 (1.5–6.1)

 

Pheterogeneity

<0.001

<0.001

Sexc

Males

1.0 (ref.)

1.0 (ref.)

Females

1.2 (1.0–1.5)

1.4 (1.1–1.7)

 

Pheterogeneity

0.13

0.01

Era of childhood cancer diagnosisd

<1970

1.0 (ref.)

1.0 (ref.)

1970–1979

1.3 (1.0–1.7)

9.2 (2.3–37.2)

1980–1989

1.6 (1.2–2.2)

7.3 (1.8–29.8)

1990–2008

1.9 (1.2–3.0)

2.1 (0.5–9.7)

 

Pheterogeneity

<0.001

0.001

Age at childhood cancer diagnosise

0–4 years

1.0 (ref.)

1.0 (ref.)

5–9 years

0.8 (0.6–1.1)

0.9 (0.7–1.2)

10–14 years

0.6 (0.5–0.9)

0.5 (0.3–0.7)

15–20 years

0.5 (0.4–0.7)

0.2 (0.1–0.3)

 

Ptrend

<0.001

<0.001

Attained agef

<20 years

1.0 (ref.)

1.0 (ref.)

20–29 years

3.2 (2.1–4.9)

7.6 (4.6–12.6)

30–39 years

6.9 (4.4–10.8)

22.3 (13.4–37.1)

40+ years

10.2 (6.3–16.5)

33.6 (18.9–59.8)

 

Ptrend

<0.001

<0.001

  1. CNS central nervous system, RR relative risk, CI confidence interval.
  2. aFor each exposure factor a separate multivariable Poisson regression model was employed with a different set of confounders included. A directed acyclic graph (DAG) was used to guide the choice of potential set of confounders to include in each Poisson regression model (see: dagitty.net/mrsMx0N). The factor ‘country’ was incorporated in each Poisson regression model as a random effect.
  3. bAdjusted for: age at diagnosis, attained age.
  4. cAdjusted for: no adjustments.
  5. dAdjusted for: attained age.
  6. eAdjusted for: attained age.
  7. fAdjusted for: era of childhood cancer, age at diagnosis.